Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Hockett

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Disease Markers|October 5, 2002
Pharmacogenomic biomarkersSandra C Kirkwood, Richard D Hockett
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
Pharmacogenomics in endocrinologyRichard D Hockett, Sandra C Kirkwood, Bruce H Mitlak, et al.
Pharmacogenomics|December 24, 2008
4th US FDA-Drug Information Association pharmacogenomics workshop, held 10-12 December, 2007Felix W Frueh, Ronald A Salerno, Lawrence J Lesko, et al.
Oncotarget|May 12, 2025
Analytical validation of a circulating tumor DNA assay using PhasED-Seq technology for detecting residual disease in B-cell malignanciesNina Klimova, Sandra Close, David M Kurtz, et al.
Journal of Clinical Laboratory Analysis|May 6, 2026
Assessment of Potential Sources of Variability on the Analytical Performance of a Circulating Tumor DNA Minimal Residual Disease Test for B-Cell LymphomasNina Klimova, Alanna Roff, Justine McCutcheon, et al.
The Journal of Molecular Diagnostics : JMD|July 29, 2005
Precision profiling and components of variability analysis for Affymetrix microarray assays run in a clinical contextThomas M Daly, Carmen M Dumaual, Crystal A Dotson, et al.
Pharmacogenomics|February 28, 2007
Comprehensive assessment of metabolic enzyme and transporter genes using the Affymetrix Targeted Genotyping SystemCarmen Dumaual, Xin Miao, Thomas M Daly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
A phase II trial of pemetrexed in advanced breast cancer: clinical response and association with molecular target expressionHenry L Gomez, Sergio L Santillana, Carlos S Vallejos, et al.
The New England Journal of Medicine|December 25, 2008
Cytochrome p-450 polymorphisms and response to clopidogrelJessica L Mega, Sandra L Close, Stephen D Wiviott, et al.
Clinical Chemistry|May 19, 2007
Multiplex assay for comprehensive genotyping of genes involved in drug metabolism, excretion, and transportThomas M Daly, Carmen M Dumaual, Xin Miao, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Disease Markers|October 5, 2002
Pharmacogenomic biomarkersSandra C Kirkwood, Richard D Hockett
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
Pharmacogenomics in endocrinologyRichard D Hockett, Sandra C Kirkwood, Bruce H Mitlak, et al.
Pharmacogenomics|December 24, 2008
4th US FDA-Drug Information Association pharmacogenomics workshop, held 10-12 December, 2007Felix W Frueh, Ronald A Salerno, Lawrence J Lesko, et al.
Oncotarget|May 12, 2025
Analytical validation of a circulating tumor DNA assay using PhasED-Seq technology for detecting residual disease in B-cell malignanciesNina Klimova, Sandra Close, David M Kurtz, et al.
Journal of Clinical Laboratory Analysis|May 6, 2026
Assessment of Potential Sources of Variability on the Analytical Performance of a Circulating Tumor DNA Minimal Residual Disease Test for B-Cell LymphomasNina Klimova, Alanna Roff, Justine McCutcheon, et al.
The Journal of Molecular Diagnostics : JMD|July 29, 2005
Precision profiling and components of variability analysis for Affymetrix microarray assays run in a clinical contextThomas M Daly, Carmen M Dumaual, Crystal A Dotson, et al.
Pharmacogenomics|February 28, 2007
Comprehensive assessment of metabolic enzyme and transporter genes using the Affymetrix Targeted Genotyping SystemCarmen Dumaual, Xin Miao, Thomas M Daly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
A phase II trial of pemetrexed in advanced breast cancer: clinical response and association with molecular target expressionHenry L Gomez, Sergio L Santillana, Carlos S Vallejos, et al.
The New England Journal of Medicine|December 25, 2008
Cytochrome p-450 polymorphisms and response to clopidogrelJessica L Mega, Sandra L Close, Stephen D Wiviott, et al.
Clinical Chemistry|May 19, 2007
Multiplex assay for comprehensive genotyping of genes involved in drug metabolism, excretion, and transportThomas M Daly, Carmen M Dumaual, Xin Miao, et al.
Pageof 2